| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Adma Biologics, Inc. (ADMA) has 9 insiders with recent SEC Form 4 filings, including 20 buys and 0 sells. ADMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.26M | $18.35M | - | |
| Dir | 2.05M | $16.61M | - | |
| Dir | 488.9K | $3.97M | - | |
| COO | 446.2K | $3.62M | - | |
| Dir | 263.0K | $2.14M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2015 | Grossman Adam S66 | President &CEO | Buy | 1,800 | $9.18 | $16,528.86 | +0.3% | |
| Nov 20, 2015 | Grossman Adam S66 | President &CEO | Buy | 3,861 | $9.21 | $35,572.00 | +0.2% | |
| Mar 19, 2015 | Lenz Brian | Chief Financial Officer | Buy | 750 | $8.95 | $6,714.00 | +8.6% | |
| Mar 19, 2015 | Grossman Adam S66 | President &CEO | Buy | 2,000 | $8.50 | $16,996.80 | +0.3% | |
| Mar 17, 2015 | Grossman Jerrold B68 | Director | Buy | 1,700 | $8.00 | $13,601.78 | +0.1% | |
| Mar 17, 2015 | Grossman Adam S66 | President &CEO | Buy | 14,600 | $8.01 | $116,940.63 | +0.4% | |
| Mar 16, 2015 | Mond James | Cso/ CMO | Buy | 1,250 | $8.02 | $10,025.00 | +95.1% | |
| Mar 16, 2015 | Lenz Brian | Chief Financial Officer | Buy | 1,250 | $7.97 | $9,961.25 | +41.7% | |
| Mar 16, 2015 | Guiheen Lawrence P.70 | Director | Buy | 1,000 | $7.96 | $7,959.00 | +20.0% | |
| Mar 13, 2015 | Richman Eric I79 | Director | Buy | 3,500 | $7.88 | $27,570.00 | +140.0% |